-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
"we are calling for the immediate implementation of a statutory duty of candour for the health trusts."
.
the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010.
.
the patient was treated at the royal devon & exeter nhs foundation trust.
.